• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别少数群体患者的雄激素性脱发。

Androgenetic Alopecia in Gender Minority Patients.

机构信息

Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, Suite 200, Boston, MA 02114, USA.

Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, Suite 200, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA.

出版信息

Dermatol Clin. 2020 Apr;38(2):239-247. doi: 10.1016/j.det.2019.10.010. Epub 2019 Nov 26.

DOI:10.1016/j.det.2019.10.010
PMID:32115134
Abstract

Androgenetic alopecia (AGA) is the most common type of hair loss in adults and may be particularly distressing for gender minority patients, given the close relation between hair and gender expression. Furthermore, use of gender affirming hormones such as testosterone in transmen and estrogen/antiandrogens in transwomen has a direct effect on hair growth distribution and density. Clinicians should thus be knowledgeable about the effects of sex hormones on the hair growth cycle to comfortably diagnose and treat AGA in gender minority patients.

摘要

雄激素性脱发(AGA)是成年人最常见的脱发类型,对于性别少数群体患者来说可能特别令人苦恼,因为头发与性别表达密切相关。此外,跨性别男性使用睾酮等性别肯定激素,跨性别女性使用雌激素/抗雄激素,这些都会直接影响头发的生长分布和密度。因此,临床医生应该了解性激素对毛发生长周期的影响,以便舒适地诊断和治疗性别少数群体患者的 AGA。

相似文献

1
Androgenetic Alopecia in Gender Minority Patients.性别少数群体患者的雄激素性脱发。
Dermatol Clin. 2020 Apr;38(2):239-247. doi: 10.1016/j.det.2019.10.010. Epub 2019 Nov 26.
2
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.跨性别和性别多样化人群中的雄激素性脱发:治疗方法综述。
J Am Acad Dermatol. 2023 Oct;89(4):774-783. doi: 10.1016/j.jaad.2021.08.067. Epub 2021 Oct 28.
3
Pattern hair loss in men: diagnosis and medical treatment.男性型脱发:诊断与治疗。
Dermatol Clin. 2013 Jan;31(1):129-40. doi: 10.1016/j.det.2012.08.003. Epub 2012 Sep 21.
4
Nonsurgical therapy for hair loss.脱发的非手术治疗。
Facial Plast Surg Clin North Am. 2013 Aug;21(3):335-42. doi: 10.1016/j.fsc.2013.04.003.
5
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.非手术治疗雄激素性脱发的疗效:一项系统评价和网状Meta分析
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2112-2125. doi: 10.1111/jdv.15081. Epub 2018 Jul 11.
6
Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism.脱发的类型及治疗选择,包括新型低能量光疗法及其作用机制。
South Med J. 2010 Sep;103(9):917-21. doi: 10.1097/SMJ.0b013e3181ebcf71.
7
Androgenetic alopecia and current methods of treatment.雄激素性脱发及其当前治疗方法。
Acta Dermatovenerol Alp Pannonica Adriat. 2005 Mar;14(1):5-8.
8
[Androgenetic alopecia in the man].男性雄激素性脱发
Ther Umsch. 2002 May;59(5):211-6. doi: 10.1024/0040-5930.59.5.211.
9
Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of androgenetic alopecia in males.微针联合5%米诺地尔溶液及非那雄胺治疗男性雄激素性脱发的临床疗效
Arch Dermatol Res. 2025 Feb 15;317(1):428. doi: 10.1007/s00403-025-03891-y.
10
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.一项关于0.25%非那雄胺与3%米诺地尔混合外用溶液对比3%米诺地尔溶液治疗男性雄激素性脱发疗效和安全性的随机双盲对照研究。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20.

引用本文的文献

1
Psychological stress impact neurotrophic factor levels in patients with androgenetic alopecia and correlated with disease progression.心理压力影响雄激素性脱发患者的神经营养因子水平,并与疾病进展相关。
World J Psychiatry. 2024 Oct 19;14(10):1437-1447. doi: 10.5498/wjp.v14.i10.1437.
2
Dermatological care of gender-diverse patients in Australia.澳大利亚性别多元化患者的皮肤科护理。
Australas J Dermatol. 2024 Dec;65(8):601-609. doi: 10.1111/ajd.14360. Epub 2024 Aug 8.
3
Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.
描述跨性别群体中的皮肤病状况:一项横断面研究。
Transgend Health. 2023 Feb 8;8(1):89-99. doi: 10.1089/trgh.2021.0105. eCollection 2023 Feb.
4
Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents.处理跨性别青少年性别肯定治疗的皮肤学影响
Adolesc Health Med Ther. 2022 Oct 7;13:93-106. doi: 10.2147/AHMT.S344078. eCollection 2022.
5
Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals.针对非二元性别的跨性别者量身定制的激素治疗策略。
J Clin Med. 2020 May 26;9(6):1609. doi: 10.3390/jcm9061609.